Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

HYPERDIAMOND · The Diamond Revolution in Hyperpolarized MR Imaging – Novel Platform and Nanoparticle Targeted Probe

H2020Status: CLOSED1 January 201630 June 2020EU funding €4,866,050Call H2020-PHC-2014-2015

Non-invasively imaging small numbers of molecular probes, to help image particular targets or pathways in vivo, is currently undergoing a technological revolution. Recent breakthroughs in molecular hyperpolarization proved > 10,000-fold increase in sensitivity on conventional magnetic resonance imaging (MRI) systems, thus providing insight into previously unseen metabolic processes with enormous potential for socioeconomic relevant diseases. E.g. pyruvate-based hyperpolarized imaging was clinically demonstrated to be effective for prostate cancer diagnostics in human patients. However, the current state-of-the-art hyperpolarization methods are expensive and cumbersome, limiting the access to hyperpolarization technology, and require long hyperpolarization times of 60-90 minutes per dosage; hyperpolarization probes exhibit short hyperpolarization duration (1-5 minutes), limiting the usage of hyperpolarization to metabolic imaging. A quantum technological breakthrough, Nitrogen-Vacancy defects (NV centres) in diamonds, is set to revolutionize the field of hyperpolarization for both hyperpolarizer and probes. The primary objective of HYPERDIAMOND is the development and commercialization of two new molecular imaging technologies for sensitive diagnosis and treatment monitoring, based on NV centres:The Diamond Hyperpolarizer will offer a cost- and time-effective solution for hyperpolarization that easily fits current MRI layouts, hyperpolarizes within 5 minutes, and improves clinical viability. The Nano-diamond (ND) Probe will introduce the first targeted MRI probe capable of achieving comparable molecular sensitivity to positron emission tomography (PET) with MRI systems, exhibiting extremely long hyperpolarization duration (~1 hour), and enabling non-metabolic hyperpolarized imaging. HYPERDIAMOND will bridge the gap between novel quantum and nanotechnology and their applications in hyperpolarized imaging, producing innovation not feasible with current technology.

Consortium · 14 organisations

coordinator

UNIVERSITAET ULM

DE · €1,233,863

participant

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH

AT · €379,661

participant

KANFIT LTD

IL · €272,805

thirdParty

LAPUNTUH-MAGNETICS LTD

IL

participant

LM VAN MOPPES AND SONS SA

CH

participant

NVISION QUANTUM TECHNOLOGIES GMBH

DE · €685,625

participant

KARLSRUHER INSTITUT FUER TECHNOLOGIE

DE · €390,125

participant

RESEARCH FUND OF THE HADASSAH MEDICAL ORGANIZATION (R.A)

IL · €427,750

participant

PNO Innovation

FR · €282,580

thirdParty

MICRODIAMANT AG

CH

participant

UNIVERSITE DE TOURS

FR · €627,382

participant

THE HEBREW UNIVERSITY OF JERUSALEM

IL · €200,150

participant

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

DE · €366,108

thirdParty

PNO INNOVATION GMBH

DE

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.